New & Noteworthy

October 2022

Glycemic Control Marker

EKF Diagnostics

The FDA-cleared Lucica Glycated Albumin-L test kit (manufactured by Asahi Kasei Pharma Corp and sold by EKF Diagnostics) is a specific, quantitative test for glycated albumin, and is used for the intermediate term monitoring of glycemic control for patients with diabetes. The test kit utilizes an enzymatic methodology and is used on compatible clinical chemistry analyzers with open channel capability. It determines both glycated albumin and total albumin in separate reactions, and the results are expressed as a ratio (%), minimizing differences in albumin concentrations between patients. It is also standardized to an established reference material.

Request More Information

Current Issue